Method for reducing serum uric acid levels

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3144

Patent

active

040525090

ABSTRACT:
Novel pharmaceutical compositions containing as the active ingredient the compound 5-methyl-1-phenyl-2-(1H)-pyridone are described. Such compositions have been found to have a metabolic property which causes significant lowering of serum uric acid levels in humans and other mammals. The compositions containing 5-methyl-1-phenyl-2-(1H)-pyridone caused no irritation on oral administration or when applied to specific target tissues showed no significant irritation or other sequelae.

REFERENCES:
patent: 3644626 (1972-02-01), Witzel
patent: 3655897 (1972-04-01), Witzel
patent: 3715358 (1973-02-01), Witzel et al.
patent: 3721676 (1973-03-01), Witzel et al.
The Merck Manual, of Diagnosis and Therapy, 12th Edition, (1972), pp. 1101-1107.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for reducing serum uric acid levels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for reducing serum uric acid levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing serum uric acid levels will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1775521

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.